Literature DB >> 9150479

Nephropathy of type II diabetes: evidence for hereditary factors?

K Strojek1, W Grzeszczak, E Morawin, M Adamski, B Lacka, H Rudzki, S Schmidt, C Keller, E Ritz.   

Abstract

Family studies point to an important genetic element in the genesis of diabetic nephropathy, but it is not known whether renal abnormalities are present prior to the onset of diabetes. To address this issue we examined all consecutive patients suffering from type II diabetes with a duration of more than 10 years who attended a diabetes outpatient clinic. Ninety-four patients had nephropathy, 307 did not. All offspring who were phenotypically normal (no hypertension, normal oral glucose tolerance, non-smoking) and agreed to participate were examined, 26 from nephropathic and 30 from non-nephropathic diabetic parents. They were compared with 30 offspring matched for age, gender and BMI from non-diabetic parents as controls. We measured urinary albumin excretion under baseline conditions and at several time points after ingestion of 300 g cooked beef and submaximal treadmill exercise, respectively. In addition, casual blood pressure, ambulatory blood pressure, urinary albumin and urinary alpha-1-microglobulin were measured. Primary renal disease was excluded by clinical examination. Under baseline conditions, median urinary albumin excretion rate (AER; microgram/min) was significantly (P < 0.005) higher in offspring of nephropathic type II diabetic patients (7.8; range 1.04 to 19.5) than in the offspring of non-nephropathic type II diabetic patients (4.8; 0.36 to 17.5) and controls (4.4; 0.16 to 18.4). Submaximal treadmill exercise caused a greater proportional increase of AER in offspring of nephropathic type II diabetics (median 16-fold) than in offspring of non-nephropathic diabetic patients (6.3-fold) or controls (4.8-fold). In offspring of nephropathic diabetic patients casual and particularly ambulatory systolic blood pressures were significantly higher, but AER was not correlated with blood pressure. In summary, higher values, albeit within the normal range, for baseline and postexercise albuminuria were noted in phenotypically normal offspring of parents with type II diabetes and nephropathy. The observation suggests that changes in transglomerular albumin traffic are demonstrable prior to the onset of diabetes and diabetic nephropathy in subjects with a potential genetic predisposition to these conditions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9150479     DOI: 10.1038/ki.1997.220

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

Review 1.  [Nephropathy and hypertension in type II diabetes].

Authors:  E Ritz; K Bergis; K Strojek; C Keller
Journal:  Med Klin (Munich)       Date:  1997-07-15

2.  Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: a meta-analysis.

Authors:  Elias Zintzaras; Katrin Uhlig; George N Koukoulis; Afroditi A Papathanasiou; Ioannis Stefanidis
Journal:  J Hum Genet       Date:  2007-09-06       Impact factor: 3.172

3.  Association between the GLUT1 gene polymorphism and the risk of diabetic nephropathy: a meta-analysis.

Authors:  Elias Zintzaras; Ioannis Stefanidis
Journal:  J Hum Genet       Date:  2005-01-29       Impact factor: 3.172

4.  DHEA induces 11 -HSD2 by acting on CCAAT/enhancer-binding proteins.

Authors:  Zoltan Balazs; Roberto A S Schweizer; Felix J Frey; Françoise Rohner-Jeanrenaud; Alex Odermatt
Journal:  J Am Soc Nephrol       Date:  2007-11-21       Impact factor: 10.121

5.  Association of aldosterone synthase (CYP11B2) -344 T/C polymorphism with diabetic nephropathy: A meta-analysis.

Authors:  Haiyan Xu; Xu Wang; Mingming Liu; Xin Shao; Xueyuan He
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-03-23       Impact factor: 1.636

6.  The contribution of genetic variants of SLC2A1 gene in T2DM and T2DM-nephropathy: association study and meta-analysis.

Authors:  I Stefanidis; M Tziastoudi; E E Tsironi; E Dardiotis; S V Tachmitzi; A Fotiadou; G Pissas; K Kytoudis; M Sounidaki; G Ampatzis; P R Mertens; V Liakopoulos; T Eleftheriadis; G M Hadjigeorgiou; M Santos; E Zintzaras
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.